• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米技术在肝癌治疗中的应用:进展与展望。

The use of nanotechnology to combat liver cancer: Progress and perspectives.

机构信息

Department of Chemistry, University of Miami, Coral Gables, FL 33146, USA; Department of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.

Department of Chemistry, University of Miami, Coral Gables, FL 33146, USA.

出版信息

Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188621. doi: 10.1016/j.bbcan.2021.188621. Epub 2021 Aug 27.

DOI:10.1016/j.bbcan.2021.188621
PMID:34454983
Abstract

Liver cancer is one of the most common cancers worldwide and is also one of the most difficult cancers to treat, resulting in almost one million deaths per year, and the danger of this cancer is compounded when the tumor is nonresectable. Hepatocellular carcinoma (HCC) is the most common type of liver cancer and has the third highest mortality rate worldwide. Considering the morbid statistics surrounding this cancer it is a popular research topic to target for better therapy practices. This review summarizes the role of nanotechnology in these endeavors. Nanoparticles (NPs) are a very broad class of material and many different kinds have been used to potentially combat liver cancer. Gold, silver, platinum, metal oxide, calcium, and selenium NPs as well as less common materials are all inorganic NPs that have been used as a therapeutic, carrier, or imaging agent in drug delivery systems (DDS) and these efforts are described. Carbon-based NPs, including polymeric, polysaccharide, and lipid NPs as well as carbon dots, have also been widely studied for this purpose and the role they play in DDS for the treatment of liver cancer is illustrated in this review. The multifunctional nature of many NPs described herein, allows these systems to display high anticancer activity in vitro and in vivo and highlights the advantage of and need for combinatorial therapy in treating this difficult cancer. These works are summarized, and future directions are presented for this promising field.

摘要

肝癌是世界上最常见的癌症之一,也是最难治疗的癌症之一,每年导致近 100 万人死亡,当肿瘤不可切除时,这种癌症的危险性就会增加。肝细胞癌(HCC)是最常见的肝癌类型,其死亡率在全球范围内排名第三。考虑到这种癌症的严重统计数据,针对更好的治疗方法进行研究是一个热门的研究课题。这篇综述总结了纳米技术在这些努力中的作用。纳米粒子(NPs)是一类非常广泛的材料,已经使用了许多不同的 NPs 来潜在地对抗肝癌。金、银、铂、金属氧化物、钙和硒 NPs 以及不太常见的材料都是无机 NPs,已被用作药物递送系统(DDS)中的治疗剂、载体或成像剂,这些努力都有描述。碳基 NPs,包括聚合物、多糖和脂质 NPs 以及碳点,也被广泛研究用于此目的,本文综述了它们在 DDS 中治疗肝癌中的作用。本文所述的许多 NPs 的多功能性质使这些系统在体外和体内具有高抗癌活性,并突出了组合治疗在治疗这种难治性癌症中的优势和必要性。这些工作被总结,并为这一有前途的领域提出了未来的方向。

相似文献

1
The use of nanotechnology to combat liver cancer: Progress and perspectives.纳米技术在肝癌治疗中的应用:进展与展望。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188621. doi: 10.1016/j.bbcan.2021.188621. Epub 2021 Aug 27.
2
pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.用于共递送阿霉素和姜黄素以通过增强促凋亡和抗血管生成活性来治疗癌症的pH敏感聚合物纳米颗粒。
Acta Biomater. 2017 Aug;58:349-364. doi: 10.1016/j.actbio.2017.04.029. Epub 2017 Apr 26.
3
Thinking small, doing big: Current success and future trends in drug delivery systems for improving cancer therapy with special focus on liver cancer.小处着手,大处着眼:用于改善癌症治疗的药物递送系统的当前成功和未来趋势,特别关注肝癌。
Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:328-341. doi: 10.1016/j.msec.2018.11.001. Epub 2018 Nov 7.
4
The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective.纳米技术在诊断和治疗内分泌紊乱中的应用:当前趋势、毒理学和未来展望的综述。
Int J Nanomedicine. 2024 Sep 25;19:9921-9942. doi: 10.2147/IJN.S477835. eCollection 2024.
5
Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.利用纳米尺度上的贵金属和不同的限制特性,以多种方式检测和破坏癌细胞。
Acc Chem Res. 2012 Nov 20;45(11):1854-65. doi: 10.1021/ar2003122. Epub 2012 Apr 30.
6
[Advances in Nanotechnology-Based Drug Delivery Systems in the Treatment of Hepatocellular Carcinoma].基于纳米技术的药物递送系统在肝细胞癌治疗中的进展
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Jun;46(3):384-392. doi: 10.3881/j.issn.1000-503X.15669.
7
Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.基于纳米技术的神经退行性疾病靶向治疗:神经药物高效递送的有前途工具。
Curr Drug Targets. 2020;21(8):819-836. doi: 10.2174/1389450121666200106105633.
8
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.无机纳米粒子在癌症治疗中的应用:从实验室到临床的转变。
Curr Med Chem. 2018;25(34):4269-4303. doi: 10.2174/0929867325666171229141156.
9
Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.纳米技术与纳米植物化学物质的最新进展:癌症进展中的分子机制及临床意义
Int J Mol Sci. 2021 Mar 30;22(7):3571. doi: 10.3390/ijms22073571.
10
Current status of nanomaterial-based treatment for hepatocellular carcinoma.基于纳米材料的肝癌治疗的现状。
Biomed Pharmacother. 2019 Aug;116:108852. doi: 10.1016/j.biopha.2019.108852. Epub 2019 Apr 15.

引用本文的文献

1
Application of Nanotechnology in TACE Treatment of Liver Cancer.纳米技术在肝癌经动脉化疗栓塞治疗中的应用
Int J Nanomedicine. 2025 Aug 4;20:9621-9639. doi: 10.2147/IJN.S527518. eCollection 2025.
2
Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers.生物膜包被的纳米系统作为治疗胃肠道癌症的下一代递送系统。
Bioeng Transl Med. 2025 Feb 26;10(4):e70006. doi: 10.1002/btm2.70006. eCollection 2025 Jul.
3
Prognostic poteintial of polyamine metabolism-related genes in hepatocellular carcinoma.
多胺代谢相关基因在肝细胞癌中的预后潜力
Sci Rep. 2025 Jul 2;15(1):23648. doi: 10.1038/s41598-025-08496-z.
4
Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma.纳米材料在肝细胞癌经动脉化疗栓塞治疗中的现状与最新进展
World J Clin Oncol. 2025 Apr 24;16(4):104435. doi: 10.5306/wjco.v16.i4.104435.
5
Assessing the Impact of Multidisciplinary Team (MDT) Care on Patients with Liver Cancer/Cirrhosis: A Systematic Review and Meta-Analysis.评估多学科团队(MDT)护理对肝癌/肝硬化患者的影响:一项系统评价和荟萃分析。
Iran J Public Health. 2025 Feb;54(2):240-251.
6
Bibliometric analysis of nanoparticle research for diagnostics and therapeutics in hepatocellular carcinoma.肝细胞癌诊断与治疗中纳米颗粒研究的文献计量分析
Discov Nano. 2025 Mar 30;20(1):61. doi: 10.1186/s11671-025-04226-6.
7
Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study.超越文字:肝细胞癌中的纳米技术——一项文献计量学研究
Front Oncol. 2025 Jan 15;14:1487198. doi: 10.3389/fonc.2024.1487198. eCollection 2024.
8
β-catenin attenuation by a mefloquine-loaded core-shell nano emulsion strategy to suppress liver cancer cells.通过载有甲氟喹的核壳纳米乳液策略减弱β-连环蛋白以抑制肝癌细胞。
Nanoscale Adv. 2024 Nov 27;7(3):748-765. doi: 10.1039/d4na00547c. eCollection 2025 Jan 28.
9
Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma.药物重定位方法鉴定用于肝细胞癌的候选药物分子。
Int J Mol Sci. 2024 Aug 29;25(17):9392. doi: 10.3390/ijms25179392.
10
An In-depth Review on in the Management of Liver Health and Liver Cancer.关于肝脏健康与肝癌管理的深入综述。
Anticancer Agents Med Chem. 2025;25(1):24-34. doi: 10.2174/0118715206307964240821051756.